Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
4440.2%
Followers on X. Updated Oct 10, 2026
Loading...

Elicio Therapeutics X Follower Count

Elicio Therapeutics has 444 followers on X (formerly Twitter), roughly flat (+1.4%) over the past three months.

With 444 followers, Elicio Therapeutics has a smaller X following than industry peers like Amgen (118,617) and Gilead Sciences (72,276).

How Elicio Therapeutics’s X Growth Feeds the ELTX AI Score

X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Elicio Therapeutics’s X following into the ELTX AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.

For Elicio Therapeutics’s reach on other platforms, see Elicio Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.

For real-time conversation volume, see ELTX X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.

Month over Month X Followers

Aug 2026 437
Jul 2026 438
Jun 2026 430
May 2026 418
Get ELTX alerts in real-time
The moment the x followers trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Elicio Therapeutics X (Twitter) Followers: Frequently Asked Questions

Elicio Therapeutics has 444 followers (444) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.

Elicio Therapeutics's X following has been roughly flat (+1.4%) over the past three months. View the trend chart above for the full history.

X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Elicio Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Elicio Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Elicio Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.

With fewer than 1,000 followers, Elicio Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.

Sign up and get more insights on Elicio Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.